# Allarity Therapeutics, Inc.: Form 8-K, filed Jan 29, 2026

- Company: [Allarity Therapeutics, Inc.](/companies/allr.md) (CIK 1860657)
- Form: 8-K
- Filed: 2026-01-29
- Accepted by EDGAR: Jan 29, 2026, 07:49 ET
- Period: 2026-01-28
- Accession: 0001213900-26-009157
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1860657/000121390026009157/ea0274173-8k_allarity.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1860657/000121390026009157/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1860657/000121390026009157/ea0274173-8k_allarity.htm

Filed Jan 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-009157. Last ingested by Listed: Nov 2, 2026, 08:01 ET. No prices; not investment advice.